Polymethoxylated N ‐Carboranyl Isoquinolinones: A New Scaffold for ABCG2 Inhibitors
ChemMedChem · 2026
DOI: 10.1002/cmdc.202500708 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Lydia Kuhnert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Universität Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily G, Member 2, Neoplasm Proteins, Antineoplastic Agents, Isoquinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, European Chiropractors' Union, Graduate School Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa).
Abstract (Originalsprache)
ABCG2‐mediated multidrug resistance (MDR) is a major challenge among chemotherapeutic treatments of colon, pancreatic, and breast cancer, as well as leukemia. Clinical oncology seeks new adjuvant therapeutics to overcome MDR by developing potent but nontoxic ABCG2 inhibitors. Aided by computational docking analyses, based on known substrate and inhibitor structural motifs, a new isoquinolinone framework and several (poly)methoxylated derivatives were designed and synthesized. The novel carborane‐containing N ‐carboranyl isoquinolinones were evaluated for cytotoxicity, ABCG2 inhibition, and reversal of MDR in combination with mitoxantrone (MXN) in an ABCG2‐expressing Madin–Darby canine kidney II cell model. While the parental compound IC‐1 showed strong ABCG2 inhibition, its 4‐methoxyphenyl, 3,4‐dimethoxyphenyl, and 3,4,5‐trimethoxyphenyl derivatives ( IC‐4 , IC‐5, and IC‐6 ) exhibited improved ABCG2 affinity. Nonsubstituted isoquinolinones IC‐1 to IC‐6 displayed higher solubility, lower toxicity, and similar ABCG2 inhibition and reversal of MXN resistance than 6,7‐dimethoxy‐isoquinolinone derivatives IC‐7 to IC‐11 . Especially, the 4‐methoxyphenyl‐ and 3,4‐dimethoxyphenyl‐substituted isoquinolinones ( IC‐10 , IC‐11 ) caused the strongest left shift of the MXN IC 50 value by 8.1‐ and 7.2‐fold, indicating effective resensitization to the chemotherapeutic agent. Therefore, carborane‐containing isoquinolinones featuring additional methoxy groups represent a promising approach for the development of ABCG2 inhibitors to overcome resistance to anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Universität Leipzig, Leipzig, Germany.
- Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Universität Leipzig, Leipzig, Germany.
- Centre for Biotechnology and Biomedicine (BBZ), Faculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität Leipzig, Leipzig, Germany.
- Faculty of Chemistry and Chemical Engineering, Department of Chemistry, Babeş-Bolyai University, Cluj-Napoca, Romania.
ORCID-Profile: Lydia Kuhnert, Philipp Stockmann, Peter Lönnecke, Evamarie Hey-Hawkins, Walther Honscha
Förderung
- Deutsche Forschungsgemeinschaft
- European Chiropractors' Union
- Graduate School Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)
Zitieren
APA
Kuhnert, L., Stockmann, P., Lönnecke, P., Wolniewicz, M. A., Hey-Hawkins, E., & Honscha, W. (2026). Polymethoxylated N ‐Carboranyl Isoquinolinones: A New Scaffold for ABCG2 Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202500708
Vancouver
Kuhnert L, Stockmann P, Lönnecke P, Wolniewicz MA, Hey-Hawkins E, Honscha W. Polymethoxylated N ‐Carboranyl Isoquinolinones: A New Scaffold for ABCG2 Inhibitors. ChemMedChem. 2026. doi:10.1002/cmdc.202500708
BibTeX
@article{Kuhnert2026,
author = {Kuhnert, Lydia and Stockmann, Philipp and Lönnecke, Peter and Wolniewicz, Mara Anna and Hey-Hawkins, Evamarie and Honscha, Walther},
title = {Polymethoxylated N ‐Carboranyl Isoquinolinones: A New Scaffold for ABCG2 Inhibitors},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.202500708}
}
EUVIMED